menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Are too many Americans taking antidepressants?

8 0
10.09.2026

Drugs for treating depression are among the most prescribed category of medications in the U.S. – 1 in 6 American adults take them.

Some health researchers and advocates have raised concerns that too many patients are using antidepressants and that patients who want to stop taking them struggle to do so. One of the most prominent voices on this point is Health and Human Services Secretary Robert F. Kennedy Jr., who launched an effort in May 2026 encouraging doctors to find [other ways besides antidepressants and other psychiatric drugs] to treat depression when possible.

As a psychiatrist for over 35 years, including a past role as the medical director of North Dakota’s Department of Human Services, I’ve seen both the benefits and the problems with antidepressants. In my view, there are grains of truth to claims that they are overused, but the full picture is much more nuanced.

What are antidepressants, and who takes them?

Over half of all antidepressant medications prescribed are a type of drug called selective serotonin reuptake inhibitors, or SSRIs. The first SSRI – fluoxetine, better known by its brand name Prozac – was approved in 1987. A handful of other types of SSRIs, which work through different mechanisms, also exists.

Antidepressants can be helpful for moderate to severe depression, but they are typically not warranted for mild depression, as the side effects might outweigh any potential benefits. For mild depression, many effective nonmedication treatments exist.

However, the distinction between mild and more severe symptoms sometimes gets lost. In everyday language, people use the term “depression” to describe everything from a minor sense of the blahs to a serious clinical condition requiring treatment.

Healthcare workers in primary care clinics routinely screen patients for depression using a widely used questionnaire. This tool can be........

© The Conversation